Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000473460) titled 'A clinical study to compare the safety and tolerability of two formulations of a new drug in Healthy Participants for Parkinson's disease' on May 16.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Crossover
Type of endpoint: Bio-availability
Primary Sponsor: Gain Therapeutics, Australia Pty Ltd (local Sponsor)
Condition:
Parkinson's Disease
Parkinson's Disease
Neurological - Parkinson's disease
Intervention:
This is a Phase 1, single center, open-label, randomized, single-dose, 2-period, crossover study in h...